Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date

3220 results found

2024 ∙ Sorrentino, M. Belpiede, A. Fiorilla, C. Mercogliano, M. Triassi, M. Palladino, R.

Logistic and organizational barriers to herpes zoster vaccination in europe: A systematic review

  • Europe
  • Older adults
  • Herpes zoster
  • Logistics
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Schnyder, J. L. de Jong, H. K. Bache, B. E. Schaumburg, F. Grobusch, M. P.

Long-term immunity following yellow fever vaccination: a systematic review and meta-analysis

  • Newborn
  • Children
  • Adults
  • Yellow fever
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
High
2024 ∙ Briga, M. Goult, E. Brett, T. S. Rohani, P. Domenech de Celles, M.

Maternal pertussis immunization and the blunting of routine vaccine effectiveness: a meta-analysis and modeling study

  • Pregnant women
  • Pertussis
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Critically low
2024 ∙ Assimamaw, N. T. Endalamaw, A. Kelkay, M. M. Gonete, A. T. Terefe, B. Zeleke, K. A.

Maternal Satisfaction With Children's Vaccination and Its Contributing Factors in Ethiopia: A Systematic Review and Meta-Analysis

  • Africa
  • Ethiopia
  • Parents/caregivers
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Packham, A. Taylor, A. E. Karangwa, M. P. Sherry, E. Muvunyi, C. Green, C. A.

Measles Vaccine Coverage and Disease Outbreaks: A Systematic Review of the Early Impact of COVID-19 in Low and Lower-Middle Income Countries

  • All age groups
  • Low and Middle Income Countries
  • Measles
  • Coverage
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Endalamaw, D. Nibret, E. Munshea, A. Mekonnen, F. Tadesse, S. Zeru, T. Tefera, M. Yismaw, G.

Measles vaccine effectiveness in African children: a systematic review and meta-analysis

  • Africa
  • Newborn
  • Children
  • Measles
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Atefi, A. Ghanaatpisheh, A. Ghasemi, A. Haghshenas, H. Eyvani, K. Bakhshi, A. Esfandiari, M. A. Aram, C. Saberi, A.

Meningitis after COVID-19 vaccination, a systematic review of case reports and case series

  • All age groups
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Low
2024 ∙ Limbu, Y. B. Huhmann, B. A.

Message Effectiveness of Fear Appeals in Vaccination Communication Campaigns: A Systematic Review

  • All age groups
  • COVID-19
  • Human papillomavirus (HPV)
  • Influenza
  • Measles
  • Mumps
  • Acceptance
Methodological quality (AMSTAR 2):
Not applicable
2024 ∙ Zheng, H. Wu, S. Chen, W. Cai, S. Zhan, M. Chen, C. Lin, J. Xie, Z. Ou, J. Ye, W.

Meta-analysis of hybrid immunity to mitigate the risk of Omicron variant reinfection

  • All age groups
  • COVID-19
  • Efficacy/effectiveness
Methodological quality (AMSTAR 2):
Low
2024 ∙ Kechagias, K. S. Laleye, J. D. Drmota, J. Geropoulos, G. Kyrtsonis, G. Zafeiri, M. Triantafyllidis, K. K. Stathi, D.

Minimal change disease following COVID-19 vaccination: A systematic review

  • Adults
  • Older adults
  • COVID-19
  • Safety
Methodological quality (AMSTAR 2):
Critically low
Loading...